Vanguard Capital Management’s SpyGlass Pharma SGP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGP
Vanguard Capital Management's SGP Position: Q3 2026 in Review
Vanguard Capital Management increased its SpyGlass Pharma (SGP) stake by 52% in Q3 2026, buying an estimated $5.58M and bringing the position to 660,821 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2473.
Vanguard Capital Management first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.
- Vanguard Capital Management held 660,821 shares of SpyGlass Pharma worth $17.2M as of Q3 2026.
- Vanguard Capital Management bought 226,398 SpyGlass Pharma shares in Q3 2026, an estimated $5.58M.
- SpyGlass Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2473 holding.
- Vanguard Capital Management first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
- 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.